# Task A63: Evaluation of therapeutics and vaccines in mouse models of dengue virus

> **NIH NIH N01** · UNIVERSITY OF TEXAS MED BR GALVESTON · 2022 · $1,001,923

## Abstract

This contract provides for the development and standardization of small animal models of infectious diseases, and may include efficacy testing of candidate products, including GLP studies to support licensure.

## Key facts

- **NIH application ID:** 10563302
- **Project number:** 272201700040I-0-759302200001-1
- **Recipient organization:** UNIVERSITY OF TEXAS MED BR GALVESTON
- **Principal Investigator:** DAVID BEASLEY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,001,923
- **Award type:** —
- **Project period:** 2021-11-04 → 2022-11-03

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10563302

## Citation

> US National Institutes of Health, RePORTER application 10563302, Task A63: Evaluation of therapeutics and vaccines in mouse models of dengue virus (272201700040I-0-759302200001-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10563302. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*